This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects

NCT03102567 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Elderly

Interventions

DRUG: GLPG1205 50mg q.d.
DRUG: Placebo oral capsule
DRUG: GLPG1205 250 loading dose and 50mg q.d. maintenance dose

Sponsor

Lakefront Biotherapeutics NV